REGN
NASDAQ
$672.15
Regeneron Pharmaceuticals Inc (REGN)
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $819.18 (+21.87%)
Market Cap
$69B
EPS 5Y CAGR
+20.31%
Profit Margin
20.2%
Forward P/E
15.08
Price Chart
Valuation
Market Cap$69B
P/E15.86
Forward P/E15.08
PEG88.04
P/S4.77
P/B2.22
Profitability
Total Revenue (TTM)$15B
Gross Profit (TTM)$6.55B
EBITDA$4.17B
Profit Margin20.2%
Operating Margin17.8%
EPS$41.90
Financial Health
Debt-to-Equity6.3%
Free Cash Flow Yield7.25%
Dividend Yield0.53%
Growth & Risk
EPS 5Y CAGR+20.31%
Revenue 5Y CAGR+10.16%
FCF 5Y CAGR+14.13%
Beta (5Y)0.60
Sharpe Ratio0.68